Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2021 Jul 11;76(10):782–783. doi: 10.1016/j.crad.2021.06.010

Re: Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. A reply

D Jothimani 1,, S Danielraj 1, B Nallathambi 1, B Pandurangan 1, S Kalyanasundaram 1, K Subbiah 1, H Ramachandran 1, R Venugopal 1, D Dhas 1, M Rela 1
PMCID: PMC8272941  PMID: 34261596

Sir—We thank Wilcox et al., for their valuable comments on our study published recently.1 We prospectively compared CT against endoscopy and concluded that the former can be a reliable alternative to upper gastrointestinal (GI) endoscopy for diagnosis and grading of oesophageal varices in circumstances where the latter may not be feasible, such as during COVID-19 pandemic.2

We are fully aware that endoscopy is the reference standard for oesophageal varices surveillance. Unfortunately, there is no alternative technique in patients who are unfit for endoscopy. In the midst of COVID-19 pandemic, international bodies recommended deferring routine and surveillance endoscopic procedures. In such circumstances, portal-phase CT-guided variceal screening can be a useful tool and has been assessed elsewhere. Studies have proposed a cut-off size of 3 mm for small varices and ≥5mm for large varices.3, 4, 5 The size criteria we utilized for CT-guided screening of oesophageal varices was adapted in line with a prospective study by Dessouky et al. 6

Although Baveno classification do not discuss CT screening, Baveno VI guidelines strongly recommend non-invasive tools for the assessment of portal hypertension to avoid screening endoscopies in low-risk patients.7 Moreover, endoscopic variceal screening is usually performed between 6 months to 3 years, depending on the size of varices at the index endoscopy; an interval between CT and endoscopy <6 months may not be possible in real-world situations.

To address confounding factors in our study, endoscopic and CT images were analysed prospectively and independently by two specialists for each technique and indeterminate results were further re-evaluated by a third endoscopist and a radiologist, respectively.

We sincerely thank the authors for identifying the error in Table 2. We have attached the corrected Table below. We defer to agree with the authors that CT identifies incidental findings in patients with liver cirrhosis. A triphasic abdominal CT is often an invaluable tool in cirrhotic patients identifying hepatocellular carcinoma, defining vascular anatomy, and providing important information in patients undergoing liver transplantation, exclusion of other diagnoses, e.g., abdominal tuberculosis, extrahepatic portal vein obstruction, and importantly CT, eliminates observer bias associated with abdominal ultrasound.

In conclusion, portal venous phase of triphasic abdominal CT can be a useful tool for oesophageal varices diagnosis and grading.

Table 2. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and area under the receiver operating characteristic curve (AUROC) of computed tomography (CT) in the diagnosis of oesophageal variceal grading

CT grading No varices Small Medium Large
Sensitivity
95% CI
57.1%
27.7–82.3
85.1%
68.5–93.8
72.2%
59–82.4
94.1%
80.3–99.3
Specificity
95% CI
97.9%
93.9–99.3
92.2%
85.3–96
95.5%
88.1–98.5
88.5%
78.7–94.9
PPV
95% CI
66.6%
22.3–95.7
79.3%
60.3–92
89.6%
72.7–97.8
80%
67.5–88.5
NPV
95% CI
96.9%
91.3–99.4
94.6%
86.9–98.5
86.6%
76.8–93.4
96.8%
89–99.2
AUROC
95% CI
0.775
0.54–1
0.887
0.80–0.97
0.839
0.75–0.93
0.913
0.85–0.98
p-Value for AUC 0.015 0.00 0.00 0.00

Conflict of interest

The authors declare no conflict of interest.

References

  • 1.Wilcox G, Taylor J, Albazaz R, et al. Re: optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. Clin Radiol. 2021;76:782–783 [DOI] [PMC free article] [PubMed]
  • 2.Jothimani D., Danielraj S., Nallathambi B., et al. Optimal diagnostic tool for surveillance of oesophageal varices during COVID-19 pandemic. Clin Radiol. 2021;76(7):550.e1–550.e7. doi: 10.1016/j.crad.2021.02.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kim Y.J., Raman S.S., Yu N.C., et al. Esophageal varices in cirrhotic patients: evaluation with liver CT. AJR Am J Roentgenol. 2007;188:139–144. doi: 10.2214/AJR.05.1737. [DOI] [PubMed] [Google Scholar]
  • 4.Perri R.E., Chiorean M.V., Fidler J.L., et al. A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices. Hepatology. 2008;47:1587–1594. doi: 10.1002/hep.22219. [DOI] [PubMed] [Google Scholar]
  • 5.Tseng Y.J., Zeng X.Q., Chen J., et al. Computed tomography in evaluating gastroesophageal varices in patients with portal hypertension: a meta-analysis. Dig Liver Dis. 2016;48:695–702. doi: 10.1016/j.dld.2016.02.007. [DOI] [PubMed] [Google Scholar]
  • 6.Dessouky B.A., Abdel Aal el S.M. Multidetector CT oesophagography: an alternative screening method for endoscopic diagnosis of oesophageal varices and bleeding risk. Arab J Gastroenterol. 2013;14:99–108. doi: 10.1016/j.ajg.2013.08.006. [DOI] [PubMed] [Google Scholar]
  • 7.de Franchis R., VI Faculty Baveno. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752. doi: 10.1016/j.jhep.2015.05.022. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Radiology are provided here courtesy of Elsevier

RESOURCES